HUP0201300A2 - IL-8 receptor antagonista hatású imidazolidin ilidén-2-imino-származékok és ezeket tartalmazó gyógyszerkészítmények - Google Patents
IL-8 receptor antagonista hatású imidazolidin ilidén-2-imino-származékok és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0201300A2 HUP0201300A2 HU0201300A HUP0201300A HUP0201300A2 HU P0201300 A2 HUP0201300 A2 HU P0201300A2 HU 0201300 A HU0201300 A HU 0201300A HU P0201300 A HUP0201300 A HU P0201300A HU P0201300 A2 HUP0201300 A2 HU P0201300A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkoxy
- alkyl
- halo
- imidazoidinylidene
- Prior art date
Links
- 102000010681 interleukin-8 receptors Human genes 0.000 title 1
- 108010038415 interleukin-8 receptors Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- -1 nitro- Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 102000019034 Chemokines Human genes 0.000 abstract 1
- 108010012236 Chemokines Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány (I) általános képletű vegyületekre - amelynek képletébenképletében R hidroxi-, merkaptocsoport vagy -NHSO2Rd csoport; R1előnyösen hidrogén-; halogénatom; nitro-; ciano-; alkil-; halogén-alkil-; alkenil-; alkoxi-; halogén-alkoxi- vagy azidocsoport; R2alkilén- vagy alkeniléncsoport, amely adott esetben 1-3 oxigén-,kénatomot NR9, karbonil-, szulfinil- vagy szulfonilcsoportottartalmaz; R3 előnyösen alkil-, halogén-alkil-, alkenil-, alkoxi-,halogén-alkoxi-, azido-, -S(O)tR4, -(CR8R8)qS(O)tR4, hidroxi-,hidroxi-alkil- aril-, aralkil-, aril-oxi- vagy aril-alkoxicsoport; Yelőnyösen hidrogén-; halogénatom; nitro-; ciano- vagy alkilcsoport; més n 1, 2 vagy 3 - és a vegyületeket tartalmazó, IL-8a vagy IL-8breceptorhoz kötődő kemokin által mediált betegségek kezeléséreszolgáló gyógyszerkészítményekre vonatkozik. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13671799P | 1999-05-28 | 1999-05-28 | |
| PCT/US2000/014661 WO2000072845A1 (en) | 1999-05-28 | 2000-05-26 | Il-8 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0201300A2 true HUP0201300A2 (hu) | 2002-12-28 |
| HUP0201300A3 HUP0201300A3 (en) | 2003-02-28 |
Family
ID=22474057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201300A HUP0201300A3 (en) | 1999-05-28 | 2000-05-26 | Il-8 receptor antagonist imidazoidinylidene-2-imino derivatives and pharmaceutical compositions containing them |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6566387B1 (hu) |
| EP (1) | EP1180028B1 (hu) |
| JP (1) | JP2003500447A (hu) |
| KR (1) | KR20020010674A (hu) |
| CN (1) | CN1353606A (hu) |
| AR (1) | AR029637A1 (hu) |
| AT (1) | ATE352299T1 (hu) |
| AU (1) | AU766082B2 (hu) |
| BR (1) | BR0010843A (hu) |
| CA (1) | CA2375683A1 (hu) |
| CO (1) | CO5170514A1 (hu) |
| CZ (1) | CZ20014247A3 (hu) |
| DE (1) | DE60033145T2 (hu) |
| DK (1) | DK1180028T3 (hu) |
| ES (1) | ES2280217T3 (hu) |
| HK (1) | HK1045257A1 (hu) |
| HU (1) | HUP0201300A3 (hu) |
| IL (1) | IL146046A0 (hu) |
| MX (1) | MXPA01012268A (hu) |
| NO (1) | NO20015775L (hu) |
| NZ (1) | NZ514729A (hu) |
| PL (1) | PL351946A1 (hu) |
| PT (1) | PT1180028E (hu) |
| SI (1) | SI1180028T1 (hu) |
| TR (1) | TR200103448T2 (hu) |
| WO (1) | WO2000072845A1 (hu) |
| ZA (1) | ZA200109628B (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495569B1 (en) * | 2001-04-19 | 2002-12-17 | Millennium Pharmaceuticals, Inc. | Imidazolidine compounds |
| US7405234B2 (en) * | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
| MY143477A (en) * | 2002-10-29 | 2011-05-31 | Smithkline Beecham Corp | Il-8 receptor antagonists |
| US7820702B2 (en) | 2004-02-04 | 2010-10-26 | Bristol-Myers Squibb Company | Sulfonylpyrrolidine modulators of androgen receptor function and method |
| US7696241B2 (en) | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
| US7388027B2 (en) * | 2004-03-04 | 2008-06-17 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
| US7625923B2 (en) | 2004-03-04 | 2009-12-01 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
| JP2008517054A (ja) * | 2004-10-20 | 2008-05-22 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体アンタゴニスト |
| EP2010180A4 (en) * | 2006-04-21 | 2010-10-13 | Glaxosmithkline Llc | IL-8 RECEPTOR ANTAGONISTS |
| TWI414517B (zh) * | 2006-04-21 | 2013-11-11 | Smithkline Beecham Corp | Ｉｌ-８受體拮抗劑 |
| TW200817006A (en) * | 2006-06-23 | 2008-04-16 | Smithkline Beecham Corp | IL-8 receptor antagonist |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001501172A (ja) * | 1996-08-15 | 2001-01-30 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ―８レセプターアンタゴニスト |
| EP0939634A4 (en) * | 1996-08-15 | 2001-02-21 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
| AR008290A1 (es) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
| JP2000516621A (ja) * | 1996-08-15 | 2000-12-12 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ―８レセプターアンタゴニスト |
| JP2001527519A (ja) * | 1996-08-15 | 2001-12-25 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ―８レセプターアンタゴニスト |
| TR199901710T2 (xx) * | 1997-01-23 | 1999-09-21 | Smithkline Beecham Corporation | IL-8 resept�r antagonistleri. |
| UY25842A1 (es) * | 1998-12-16 | 2001-04-30 | Smithkline Beecham Corp | Antagonistas de receptores de il-8 |
-
2000
- 2000-05-24 AR ARP000102557A patent/AR029637A1/es not_active Application Discontinuation
- 2000-05-24 CO CO00038195A patent/CO5170514A1/es not_active Application Discontinuation
- 2000-05-26 AU AU51691/00A patent/AU766082B2/en not_active Ceased
- 2000-05-26 DK DK00936369T patent/DK1180028T3/da active
- 2000-05-26 KR KR1020017015177A patent/KR20020010674A/ko not_active Application Discontinuation
- 2000-05-26 JP JP2000620957A patent/JP2003500447A/ja active Pending
- 2000-05-26 WO PCT/US2000/014661 patent/WO2000072845A1/en active IP Right Grant
- 2000-05-26 BR BR0010843-0A patent/BR0010843A/pt not_active IP Right Cessation
- 2000-05-26 SI SI200030942T patent/SI1180028T1/sl unknown
- 2000-05-26 NZ NZ514729A patent/NZ514729A/en unknown
- 2000-05-26 CZ CZ20014247A patent/CZ20014247A3/cs unknown
- 2000-05-26 US US10/009,212 patent/US6566387B1/en not_active Expired - Fee Related
- 2000-05-26 IL IL14604600A patent/IL146046A0/xx unknown
- 2000-05-26 PL PL00351946A patent/PL351946A1/xx not_active Application Discontinuation
- 2000-05-26 TR TR2001/03448T patent/TR200103448T2/xx unknown
- 2000-05-26 CA CA002375683A patent/CA2375683A1/en not_active Abandoned
- 2000-05-26 HU HU0201300A patent/HUP0201300A3/hu unknown
- 2000-05-26 DE DE60033145T patent/DE60033145T2/de not_active Expired - Fee Related
- 2000-05-26 EP EP00936369A patent/EP1180028B1/en not_active Expired - Lifetime
- 2000-05-26 CN CN00808203A patent/CN1353606A/zh active Pending
- 2000-05-26 ES ES00936369T patent/ES2280217T3/es not_active Expired - Lifetime
- 2000-05-26 AT AT00936369T patent/ATE352299T1/de not_active IP Right Cessation
- 2000-05-26 PT PT00936369T patent/PT1180028E/pt unknown
- 2000-05-26 MX MXPA01012268A patent/MXPA01012268A/es unknown
-
2001
- 2001-11-22 ZA ZA200109628A patent/ZA200109628B/en unknown
- 2001-11-27 NO NO20015775A patent/NO20015775L/no not_active Application Discontinuation
-
2002
- 2002-07-18 HK HK02105336.0A patent/HK1045257A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01012268A (es) | 2002-07-30 |
| EP1180028A1 (en) | 2002-02-20 |
| WO2000072845A1 (en) | 2000-12-07 |
| KR20020010674A (ko) | 2002-02-04 |
| EP1180028A4 (en) | 2002-10-23 |
| PT1180028E (pt) | 2007-04-30 |
| PL351946A1 (en) | 2003-07-14 |
| CO5170514A1 (es) | 2002-06-27 |
| DE60033145T2 (de) | 2007-10-31 |
| ES2280217T3 (es) | 2007-09-16 |
| NO20015775D0 (no) | 2001-11-27 |
| AU5169100A (en) | 2000-12-18 |
| IL146046A0 (en) | 2002-07-25 |
| AU766082B2 (en) | 2003-10-09 |
| HK1045257A1 (zh) | 2002-11-22 |
| US6566387B1 (en) | 2003-05-20 |
| NZ514729A (en) | 2003-11-28 |
| DE60033145D1 (de) | 2007-03-15 |
| ATE352299T1 (de) | 2007-02-15 |
| CA2375683A1 (en) | 2000-12-07 |
| ZA200109628B (en) | 2002-11-22 |
| NO20015775L (no) | 2001-11-27 |
| TR200103448T2 (tr) | 2002-06-21 |
| CN1353606A (zh) | 2002-06-12 |
| HUP0201300A3 (en) | 2003-02-28 |
| SI1180028T1 (sl) | 2007-06-30 |
| JP2003500447A (ja) | 2003-01-07 |
| CZ20014247A3 (cs) | 2002-05-15 |
| AR029637A1 (es) | 2003-07-10 |
| BR0010843A (pt) | 2002-02-19 |
| DK1180028T3 (da) | 2007-05-21 |
| EP1180028B1 (en) | 2007-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0105437A2 (hu) | Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| ATE264337T1 (de) | Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung | |
| CO5180642A1 (es) | Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion | |
| BR0212864A (pt) | Derivados de 1,6-naftiridina como antidiabéticos | |
| CY1109498T1 (el) | 18-μεθυλο-19-νορ-17-πρεγν-4-ενο-21,17-καρβολακτονες καθως και φαρμακευτικα σκευασματα που τις περιεχουν | |
| NO308744B1 (no) | Benzimidazolderivater, deres anvendelse, og farmasøytisk preparat inneholdende disse | |
| IS2598B (is) | Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma | |
| HUP0104188A2 (hu) | Antranilsav- és tioantranilsav-N-aril-amidok, előállításuk és alkalmazásuk VEGF receptor tirozinkináz inhibítorokként | |
| HUP0500610A2 (hu) | Indazol-, benzotiazol- és benzoizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
| IL163629A0 (en) | Glutaminyl derivatives and pharmaceutical compositions containing the same | |
| BR0009007A (pt) | Derivados de piperidina, tetraidropiridina epiperazina; composto; composição farmacêutica;utilização e método | |
| HUP0401886A2 (hu) | Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| DE60118225D1 (de) | Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren | |
| HUP0201300A2 (hu) | IL-8 receptor antagonista hatású imidazolidin ilidén-2-imino-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0402019A2 (hu) | CCR5 antagonistaként alkalmazható piperidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0100865A2 (hu) | Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE60001586D1 (de) | Diphenyl-piperidin derivate | |
| DE60122555D1 (de) | Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren | |
| NO20055754L (no) | Kolkisosidanaloger | |
| BRPI0408423A (pt) | composições farmacêuticas compreendendo uma combinação de rapamicina ou seus derivados e pimecrolimus para o tratamento de doenças mediadas imunologicamente e por inflamação | |
| HUP0201302A2 (hu) | IL-8 receptor antagonista ciklusos guanidinszármazékok | |
| EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции | |
| DE69900961T2 (de) | Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
| HUP0300265A2 (hu) | Aril- és heteroaril-szulfonátok, eljárás előállításukra és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0202647A2 (hu) | Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |